Yes its a shame that investors dont stick to talking about the stock.
Basically Im in long term. Reason?
Easy - If the software in the UK proves a success, the US market is absolutly massive and no FDA approval required as there are no drugs to administer, test and certify etc.
This share will rise and rise with every country / market that the product is released in to. Even if ULT get swallowed in the advance, CB better make sure that its shareholders get the very best deal.
It can drop to .5 for all I care, my confidence is with the product which will sell itself in time.
GL